home

Mission Statement

The mission of the Psychiatric Cell Map Initiative (PCMI) is to bridge the gap between the genome and clinic in the field of neuropsychiatric disorder research by systematically mapping the physical and genetic interaction networks underlying these disorders, including autism spectrum disorders, Tourette disorder, epilepsy, intellectual disability, and schizophrenia. This will form a key resource ...

Read More

The mission of the Psychiatric Cell Map Initiative (PCMI) is to bridge the gap between the genome and clinic in the field of neuropsychiatric disorder research by systematically mapping the physical and genetic interaction networks underlying these disorders, including autism spectrum disorders, Tourette disorder, epilepsy, intellectual disability, and schizophrenia. This will form a key resource for precision medicine.

What is PCMI?

PCMI is an interdisciplinary collaborative research effort to study cell mapping of neuropsychiatric disorders.

November

21

Harnessing iPSCs and ‘omics to identify molecular convergence in neurodegeneration

Read More

July

09

PCMI All-Hands Meeting

Read More

November

17-20

PCMI and Convergent Neuroscience Meeting

Read More